SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 117 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $494,653 | -96.1% | 34,067 | -94.4% | 0.01% | -96.1% |
| Q2 2023 | $12,815,774 | -32.4% | 612,316 | -22.4% | 0.15% | -42.6% |
| Q3 2022 | $18,966,000 | +179.2% | 789,273 | +154.3% | 0.26% | +173.2% |
| Q4 2021 | $6,794,000 | -38.8% | 310,377 | -46.6% | 0.10% | -46.4% |
| Q3 2021 | $11,109,000 | +211.4% | 581,308 | +179.7% | 0.18% | +170.1% |
| Q2 2021 | $3,568,000 | +106.5% | 207,812 | +167.5% | 0.07% | +45.7% |
| Q4 2020 | $1,728,000 | – | 77,699 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
| Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
| Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
| Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
| Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
| DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
| BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |